You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 5, 2025

Details for Patent: 5,153,197


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,153,197
Title: Treatment of hypertension with angiotensin II blocking imidazoles
Abstract:Substituted imidazoles such as ##STR1## are useful as angiotensin II blockers. These compounds have activity in treating hypertension and congestive heart failure.
Inventor(s): Carini; David J. (Wilmington, DE), Duncia; John J. V. (Newark, DE)
Assignee: E. I. du Pont de Nemours and Company (Wilmington, DE)
Application Number:07/436,165
Patent Claim Types:
see list of patent claims
Use; Compound; Composition;
Patent landscape, scope, and claims:

Detailed Analysis of the Scope and Claims of United States Patent 5,153,197

Introduction

United States Patent 5,153,197, titled "Treatment of hypertension with angiotensin II blocking imidazoles," is a significant patent in the field of pharmaceuticals, particularly in the treatment of hypertension and congestive heart failure. This analysis will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Background of the Patent

The patent, issued on September 29, 1992, describes the use of substituted imidazoles as angiotensin II blockers. Angiotensin II is a potent vasoconstrictor that plays a crucial role in the renin-angiotensin-aldosterone system, which regulates blood pressure. By blocking angiotensin II, these compounds can effectively reduce blood pressure and are useful in treating hypertension and related conditions[4].

Scope of the Patent

Invention Description

The patent details the synthesis and use of specific imidazole compounds that act as angiotensin II blockers. These compounds are described in terms of their chemical structure, including the presence of specific alkyl groups and other substituents. The invention encompasses both the method of treating hypertension using these compounds and the compounds themselves[4].

Claims

The patent includes several claims that define the scope of the invention:

  • Independent Claims: These claims define the broadest scope of the invention, including the specific chemical structures of the imidazole compounds and their use in treating hypertension.
  • Dependent Claims: These claims narrow down the scope by specifying particular substituents, dosages, and methods of administration.
  • Method Claims: These claims cover the methods of treating hypertension and congestive heart failure using the imidazole compounds.

Key Claim Elements

  • Chemical Structure: The claims specify the general structure of the imidazole compounds, including the presence of certain carbon atoms, alkyl groups, and other substituents.
  • Therapeutic Use: The claims cover the use of these compounds in treating hypertension and congestive heart failure.
  • Dosage and Administration: The claims may include specific dosages and methods of administering the compounds[4].

Patent Landscape Analysis

Technological Field

The patent falls under the broader category of pharmaceuticals, specifically within the field of cardiovascular treatments. The World Intellectual Property Organization (WIPO) classifies such patents under the International Patent Classification (IPC) system, which includes categories related to organic chemistry and pharmaceutical compositions[1].

Competing Patents

The patent landscape in this field is highly competitive, with numerous patents covering various aspects of angiotensin II blockers and other hypertension treatments. Analyzing competing patents involves identifying similar claims and scope concepts to determine potential overlaps or gaps in coverage.

Claim Coverage Matrix

To understand the patent's position within the broader landscape, a Claim Coverage Matrix can be used. This tool categorizes patents by claims and scope concepts, helping to identify which patents and claims are actively protecting similar intellectual property. For US 5,153,197, this would involve comparing its claims against those of other patents in the same technological field to identify areas of overlap or unique coverage[3].

Future Design Opportunities

Using tools like Claim Charts, companies can review the patent coverage to determine if there are gaps in current protection or future design opportunities. This involves analyzing the scope concepts of the patent claims to identify high-value, medium-value, or low-value claims. For example, if the claims of US 5,153,197 are found to be highly valuable but narrow in scope, there may be opportunities to expand the coverage through new patent applications or modifications to existing claims[3].

Legal and Regulatory Considerations

Inventorship

Determining the correct inventorship is crucial for the validity of a patent. For US 5,153,197, the inventors listed must have conceived the idea of using substituted imidazoles as angiotensin II blockers and reduced this idea to practice. Incorrect or incomplete identification of inventors can lead to patent invalidity, as seen in various legal precedents[2].

Patent Validity

The patent's validity can be challenged based on various grounds, including prior art, obviousness, and deceptive intent in naming inventors. Ensuring that the patent was granted without any fraudulent activities and that the claims are novel and non-obvious is essential for maintaining its enforceability[2].

Key Takeaways

  • Scope and Claims: US 5,153,197 covers the use of specific imidazole compounds as angiotensin II blockers for treating hypertension and congestive heart failure.
  • Patent Landscape: The patent is part of a competitive landscape within the pharmaceutical field, particularly in cardiovascular treatments.
  • Claim Coverage: Analyzing the claims using a Claim Coverage Matrix and Claim Charts can help identify gaps and opportunities in patent coverage.
  • Legal Considerations: Correct inventorship and the absence of deceptive intent are critical for the patent's validity and enforceability.

FAQs

What is the main invention described in US 5,153,197?

The main invention is the use of substituted imidazoles as angiotensin II blockers for treating hypertension and congestive heart failure.

How are the claims structured in this patent?

The claims include independent claims defining the broad scope, dependent claims narrowing down the scope, and method claims covering the therapeutic use and administration of the compounds.

Why is correct inventorship important for this patent?

Correct inventorship is crucial to ensure the patent's validity and enforceability, as errors or deceptive intent can lead to the patent being declared invalid.

How can a Claim Coverage Matrix help in analyzing this patent?

A Claim Coverage Matrix helps in categorizing patents by claims and scope concepts, identifying overlaps or gaps in coverage, and determining the value of the patent claims.

What are the potential future design opportunities based on this patent?

Future design opportunities can be identified by analyzing the scope concepts of the patent claims, which can highlight areas for expanding coverage or developing new products.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 5,153,197

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 5,153,197

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 0253310 ⤷  Subscribe SPC/GB95/010 United Kingdom ⤷  Subscribe
European Patent Office 0253310 ⤷  Subscribe 96C0020 Belgium ⤷  Subscribe
European Patent Office 0253310 ⤷  Subscribe C950009 Netherlands ⤷  Subscribe
European Patent Office 0733366 ⤷  Subscribe SPC/GB98/031 United Kingdom ⤷  Subscribe
European Patent Office 0733366 ⤷  Subscribe 98C0030 Belgium ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.